Cardiovascular physicians with UC San Diego Health have joined an international clinical trial utilizing a new Extravascular Implantable Cardioverter-Defibrillator (EV ICD) system to help treat sudden cardiac arrest.
Related Articles

News
First ‘Wise Elder Changemaker’ Awards Celebrate San Diegans Age 65+
April 19, 2022
sandiegobiotech
News, UCSD News
Comments Off on First ‘Wise Elder Changemaker’ Awards Celebrate San Diegans Age 65+
Five remarkable people are being celebrated by the Life Course Scholars Program at UC San Diego with “Wise Elder Changemaker” awards for their “significant impact on people, land, communities and movements for c… […]

News
Ultrasound Remotely Triggers Immune Cells to Attack Tumors in Mice Without Toxic Side Effects
August 12, 2021
sandiegobiotech
News
Comments Off on Ultrasound Remotely Triggers Immune Cells to Attack Tumors in Mice Without Toxic Side Effects
A new cancer immunotherapy pairs ultrasound with cancer-killing immune cells to destroy malignant tumors while sparing normal tissue. The approach could make chimeric antigen receptor (CAR) T-cell therapy safer and effective at treating solid tumors. Click here to view original post… […]

News
Researchers Transform an Amorphous Solid Into a New Lithium-Ion Battery Material
May 2, 2022
sandiegobiotech
News, UCSD News
Comments Off on Researchers Transform an Amorphous Solid Into a New Lithium-Ion Battery Material
Researchers at UC San Diego and Boise State University have developed a new approach to making novel lithium-ion battery materials. The approach transforms a non-crystalline material into a crystalline anode mat… […]